|
Match
|
Document |
Document Title |
|
|
6306900 |
Enteric coated pharmaceutical compositions
This invention provides a pharmaceutical composition comprising a mycophenolate salt, the composition being adapted to release mycophenolate in the upper part of the intestinal tract.
|
|
|
6290988 |
Encapsulated material with controlled release
An encapsulated material is described of which at least a part of the material is kept encapsulated during heat treatment in an aqueous environment and is released during cooling after a heat...
|
|
|
6287594 |
Oral liquid compositions
The present invention relates to novel, liquid and semi-solid pharmaceutical compositions which can be administered in liquid form or can be used for preparing capsules containing such...
|
|
|
6267985 |
Clear oil-containing pharmaceutical compositions
The present invention relates to pharmaceutical compositions and methods for improved solubilization of triglycerides and improved delivery of therapeutic agents. Compositions of the present...
|
|
|
6267808 |
Bright white film coatings and film coating compositions therefor
A dry film coating composition used to make a bright white film coating for nutritional supplements, pharmaceutical tablets, and the like, comprises dextrose, an auxiliary film-former, and titanium...
|
|
|
6238690 |
Food products containing seamless capsules and methods of making the same
Consumable products including seamless capsules having an outer shell made of a carbohydrate material in a glassy state and an inner core.
|
|
|
6231888 |
Local delivery of non steroidal anti inflammatory drugs (NSAIDS) to the colon as a treatment for colonic polyps
A composition and method for the treatment of polyp and colon cancer is described, such composition and method providing for the colonic delivery and/or preferential metabolism of a drug or desired...
|
|
|
6228355 |
System for the control of enteropathogenic bacteria in the crops of poultry
The invention provides a method and compositions for controlling food borne enteric bacterial pathogens in poultry populations. The incidence of the colonization of poultry by enteropathogenic...
|
|
|
6228396 |
Colonic drug delivery composition
A colonic drug delivery composition is provided and comprises a starch capsule containing a drug, the starch capsule being provided with a coating such that the drug will only be released from the...
|
|
|
6214378 |
Capsules for oral preparations and capsule preparations for oral administration
This invention offers capsules for oral preparation which is useful for colon diseases such as colon cancer, ulcerative colitis, constipation and diarrhea and for systemic diseases such as...
|
|
|
6214379 |
Maximizing effectiveness of substances used to improve health and well being
The present disclosure relates to novel dosage forms, drug delivery regimens, methods and pharmaceutical compositions which optimize the therapeutic effects of active therapeutic substances through...
|
|
|
6200603 |
Comestible capsules having flavored coatings
A coated capsule is disclosed comprising a gelatin shell with a flavored coating. A sugar or sugar substitute is included in the material of the shell and that of the coating to stabilize both...
|
|
|
6200600 |
Controlled delay release device
Novel devices for the controlled release of active materials especially pharmaceuticals comprise a capsule formed from two separable pieces at least part of the capsule walls is water permeable....
|
|
|
6200602 |
Composition for enhanced uptake of polar drugs from the colon
The invention provides a drug delivery composition for colonic delivery comprising a polar drug, an absorption promoter which (a) comprises a mixture of a fatty acid having 6 to 16 carbon atoms or...
|
|
|
6187333 |
Method for treating, controlling, and preventing diabetes mellitus
This invention pertains to a method that can control, treat, and prevent Diabetes Mellitus. The method includes means of administering a potent product, including mainly the active ingredient...
|
|
|
6187340 |
Stabilized pharmaceutical preparation
A stabilized pharmaceutical preparation which is coated with a coating agent comprising an agent for the protection from light, said agent being capable of producing free radicals when exposed to...
|
|
|
6183780 |
Oral delayed immediate release formulation and method for preparing the same
The invention relates to an Oral Delayed Immediate Release formulation comprising a compressed core containing one or more active substances surrounded with a coating, wherein release of active...
|
|
|
6174873 |
Oral administration of adenosine analogs
Disclosed are compositions including an adenosine analog, wherein the composition comprises a dosage form suitable for oral (co)administration. Also disclosed are compositions including adenosine...
|
|
|
6174547 |
Dosage form comprising liquid formulation
A dosage form is disclosed comprising a drug formulation that self-emulsifies in said dosage form.
|
|
|
6172107 |
Entric-coated pharmaceutical compositions
This invention provides a pharmaceutical composition comprising a mycophenolate salt, the composition being adapted to release mycophenolate in the upper part of the intestinal tract.
|
|
|
6169118 |
Flavor blend for masking unpleasant taste of zinc compounds
A synergistic flavoring combination of at least two flavoring oils and lauryl alcohol for use in an orally administered formulation which contains an ionizable zinc compound having an undesirable...
|
|
|
6165503 |
High strength capsules, process of preparing and using the same
In the formation of capsules having a polyanionic polysaccharide core and a polycationic polysaccharide membrane layer, improved binding of the polycationic polysaccharide is achieved by including...
|
|
|
6156347 |
Controlled release chromium picolinate
The present invention relates to controlled/extended release oral dosage forms of chromium picolinate. Chromium picolinate is a common and effective biologically active form of chromium. As such,...
|
|
|
6156343 |
Controlled release preparation
A controlled release preparation consisting of a tablet containing (a) a mixture of a drug and a water-soluble polymer, or a solid dispersion thereof, (b) polyvinylalcohol and (c) one or more salts...
|
|
|
6156340 |
Orally administrable time release drug containing products
A time release orally administrable drug containing product comprising a core, a drug layer attached to the core, and first and second coating layers is disclosed. The first coating layer is...
|
|
|
6132767 |
Administering osmotic colonic evacuant containing a picosulfate
Colonic evacuation, treatment of small bowel bacterial overgrowth or irritable bowel syndrome or treating acute or chronic bacterial bowel infection comprises administering an osmotic colonic...
|
|
|
6080426 |
Process for encapsulation of caplets in a capsule and solid dosage forms obtainable by such process
A process for encapsulation of caplets in a capsule comprises the following steps: a. providing empty capsule parts; b. filling at least one of said capsule parts with one or more caplets; c....
|
|
|
6066333 |
Pharmaceutical control of inflammation
Control of inflammation is achieved by control of the level and/or activity of the enzyme heme-oxygenase (HO). A HO inducer is anti-inflammatory (FIG. 14) and used to treat inflammation, such as...
|
|
|
6030641 |
Sustained release capsule and method for preparing the same
A sustained release capsule in which an outer surface of a hard capsule mainly composed of gelatin and containing a physiologically active substance is uniformly covered with a film material...
|
|
|
6025391 |
Enteric-coated pharmaceutical compositions of mycophenolate
|
|
|
5985322 |
Method for the treatment of CNS disorders
An improved method for the treatment of central nervous system disorders comprises treating patients with an enteric fluoxetine formulation.
|
|
|
5985329 |
Particulate foods and pharmaceuticals coated with water-soluble hemicellulose
A coated product in the form of solid particles of a food or pharmaceutical wherein the particles are each coated with a water-soluble hemicellulose. The water-soluble hemicellulose has a viscosity...
|
|
|
5972685 |
Oral administration of coprostanol producing microorganisms to humans to decrease plasma cholesterol concentration
A method of decreasing plasma cholesterol is disclosed. The method includes oral administration of coprostanol-producing bacteria to humans. These organisms, once in the small intestine, will...
|
|
|
5972383 |
Solid orally administerable raloxifene hydrochloride pharmaceutical formulation
This invention provides orally administerable pharmaceutical formulations comprising raloxifene, its ethers or esters, or a pharmaceutically-acceptable salt thereof, in combination with a...
|
|
|
5968553 |
Pharmaceutical composition containing bupropion hydrochloride and an inorganic acid stabilizer
Novel, stable formulations of bupropion hydrochloride are provided which will maintain at least 80% of initial bupropion hydrochloride potency after one year. Methods of inhibiting degradation of...
|
|
|
5965160 |
Self-emulsifiable formulation producing an oil-in-water emulsion
A self-emulsifying oily formulation (SEOF) comprising an oil component and a surfactant, the SEOF being characterized in that the oil component comprises an oily carrier and a cationic lipid and...
|
|
|
5952004 |
Emulsified drug delivery systems
A pharmaceutical preparation comprising a stable, surface-active emulsion or dispersion of a pharmaceutical agent incorporated into an emulsion (i) having a hydrophobic discontinuous phase of a...
|
|
|
5952005 |
Controlled release preparation for administering morphine
An oral pharmaceutical preparation containing a therapeutically effective amount of a salt of morphine for administration once daily is provided. The preparation contains particles which have a...
|
|
|
5948427 |
Microparticulate surgical adhesive
Flowable polymeric microparticulate surgical adhesive formulations are provided which can be activated at the site of the repair to produce a cohesive material with tissue bonding properties to...
|
|
|
5902605 |
Drug delivery device with minimal residual drug retention
The present invention is directed to a fluid-imbibing drug delivery device which is useful for the initial delayed delivery of an active agent formulation to a fluid environment of use, the initial...
|
|
|
5900425 |
Pharmaceutical preparations having controlled release of active compound and processes for their preparation
The invention relates to pharmaceutical preparations having controlled release of active compound and to processes for their preparation, in particular for poorly soluble active compounds having...
|
|
|
5897876 |
Emulsified drug delivery system
A pharmaceutical preparation comprising a stable, surface-active emulsion or dispersion of a pharmaceutical agent incorporated into an emulsion (i) having a hydrophobic discontinuous phase of a...
|
|
|
5882715 |
Method of preparing an oral preparation provided on the outer side with an enteric coating, as well as an oral preparation obtained by the method
A method of preparing an oral preparation, especially in the form of hard gelatin capsules, tablets or pellets, for use by the administration of drugs or supplementary nutrients for human beings or...
|
|
|
5871774 |
Drug units and methods for use
Medical materials for use in treating maladies in living beings, such as ulcers and other conditions of the digestive tract. In one form, a container is provided for a medication which container...
|
|
|
5869102 |
Solid pharmaceutical compositions containing (S)-2-(4-isobutylphenyl) propionic acid active ingredient and microcrystalline cellulose and colloidal silica as excipients
The present invention relates to a solid pharmaceutical composition containing (S)-2-(4-isobutylphenyl) propionic acid as active ingredient and it relates to a solid pharmaceutical composition...
|
|
|
5869093 |
Treatment of immune diseases by oral administration of autoantigens
The invention is directed to a method of treating a T cell-mediated autoimmune disease in animals, including humans, by the oral administration of autoantigens, fragments of autoantigens, or...
|
|
|
5869094 |
Solid form of administration of isosorbide 5-mononitrate
A solid form of oral administration of isosorbide 5-mononitrate with a controlled, pH-independent release of the active substance in the gastro-intestinal tract is constituted by a pellet coated...
|
|
|
5866619 |
Colonic drug delivery system
A colonic delivery system for delivering a drug to the colon is provided. The system comprises a drug in combination with a matrix, wherein the matrix comprises a saccharide-containing polymer....
|
|
|
5858403 |
Picosulfate-containing preparation for colonic evacuation
An osmotic colonic evacuant in solid dosage form, which comprises a phosphate based laxative or a sulfate based laxative and preferably comprises sodium picosulfate and an antacid, is used...
|
|
|
5849327 |
Delivery of drugs to the lower gastrointestinal tract
Diseases of the colon are treated by oral ingestion of a unit dosage form containing a plurality of porous microscopic beads, the pores containing an active agent or drug and plugged with a...
|